Pfirrmann, Markus http://orcid.org/0000-0002-8948-0690
Clark, Richard E.
Prejzner, Witold
Lauseker, Michael
Baccarani, Michele
Saussele, Susanne
Guilhot, François
Heibl, Sonja
Hehlmann, Rüdiger
Faber, Edgar
Turkina, Anna http://orcid.org/0000-0001-9947-2371
Ossenkoppele, Gert
Höglund, Martin
Zaritskey, Andrey
Griskevicius, Laimonas
Olsson-Strömberg, Ulla
Everaus, Hele
Koskenvesa, Perttu
Labar, Boris
Sacha, Tomasz http://orcid.org/0000-0002-7207-6595
Zackova, Daniela
Cervantes, Francisco
Colita, Adriana
Zupan, Irena
Bogdanovic, Andrija
Castagnetti, Fausto
Guilhot, Joëlle
Hasford, Joerg
Hochhaus, Andreas
Hoffmann, Verena S.
Article History
Received: 15 May 2020
Revised: 20 May 2020
Accepted: 12 June 2020
First Online: 29 June 2020
Compliance with ethical standards
:
: The authors declare the following potential conflicts of interest: REC, Research support: Novartis, Bristol Myers Squibb. Honoraria: Novartis, Bristol Myers Squibb, Pfizer. MB, Research support: Ariad. Honoraria: Novartis, Teva, Pfizer, Juno, Astellas, Ambit. Honoraria: Novartis, BMS, Pfizer, Incyte, Ariad, Takeda, Fusion Pharma. Logistic support: Novartis, BMS, Pfizer, Incyte, Ariad. SS, Research support: Bristol Myers Squibb, Incyte, Novartis. Honoraria: Bristol Myers Squibb, Incyte, Novartis, Pfizer. EF, Research support: Angelini, Bristol Myers Squibb, Novartis. Speaker: Angelini, Bristol Myers Squibb, Novartis. Consultation: Angelini, Bristol Myers Squibb, Novartis. Travel Grants: Angelini, Bristol Myers Squibb, Novartis, Pfizer, Terumo. AT, Consultation: Novartis, Pfizer, Fusion Pharma. Honoraria: Novartis, Pfizer. AZ, Research support: Cellgene, Janssen. TS, Honoraria: Novartis, Bristol-Myers Squibb, Pfizer, Angelini. Speakers’ bureau: Novartis, Bristol-Myers-Squibb, Pfizer, Angelini. DZ, Advisory board: Novartis, Incyte. Speakers’ bureau: Bristol Myers Squibb, Angelini. Consultation: Angelini. Travel grant: Birstol Myers Squibb. FC, Advisory board: Pfizer, Bristol Myers Squibb. Speakers’ bureau: Incyte, Pfizer. AB, Honoraria: Novartis, Pfizer. Travel grant: Takeda. F Castagnetti, Consultation: Novartis, Incyte, Pfizer, Bristol Myers Squibb. Honoraria: Novartis, Incyte, Pfizer, Bristol Myers Squibb. AH, Research support: Novartis, BMS, Pfizer, Incyte. MP, WP, FG, ML, SH, RH, GO, MH, LG, UOS, HE, PK, BL, AC, IZ, JG, JH, and VSH declare no potential competing interests.
: All studies complied with the Declaration of Helsinki. They were approved by the local human investigations committee and performed in accordance with the legal requirements of the corresponding country. Informed consent was obtained from all patients.